SLCTR_2022_008
Short term vaccine reactions due to mixing and matching of COVID-19 vaccines
Heterologous covid-19 vaccine intervention effect on reactogenicity
Public Sector Medical College, Rawalpindi·Phase 4·Sri Lanka Clinical Trials RegistryRecruiting
Study focus
- Disease/Condition
- Reactogenicity of vaccine
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Public Sector Medical College, Rawalpindi
- Location
- Pakistan
Timeline & enrollment
- Phase
- Phase 4
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Vaccine or biological substance, unspecifiedBacterial vaccinesOther specified vaccines and biological substancesViral vaccinesOther and unspecified vaccines and biological substances
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2022_008
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2022_008 through Pure Global AI's free database. This Phase 4 trial is sponsored by Public Sector Medical College, Rawalpindi and is currently Recruiting. The study focuses on Reactogenicity of vaccine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.